Pacira Pharmaceuticals Inc to Acquire MyoScience Inc - M&A Call Transcript
Good day, ladies and gentlemen, and welcome to the Pacira Acquire MyoScience Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded. I will now like to introduce your host for today's conference, Susan Mesco, Head of Investor Relations. You may begin.
Thank you, Ashley, and good morning, everyone. Welcome to today's conference call to discuss our acquisition of MyoScience. Joining me are Dave Stack, Chairman and Chief Executive Officer; Ron Ellis, our Senior Vice President of Strategy and Corporate Development; and Charlie Reinhart, our Chief Financial Officer. Before we start, let me remind you that today's call will include forward-looking statements based on current expectations. Such statements represent our judgment as of today and may involve risks and uncertainties. Please refer to our filings with the SEC, which are available from the SEC or our website for information concerning the risk factors that could affect the company. We will be using slides on today's
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |